Cargando…

Rapamycin Treatment Alleviates Chronic GVHD-Induced Lupus Nephritis in Mice by Recovering IL-2 Production and Regulatory T Cells While Inhibiting Effector T Cells Activation

In this study, we test the therapeutic effects of rapamycin in a murine model of SLE-like experimental lupus nephritis induced by chronic graft-versus-host disease (cGVHD). Our results suggest that rapamycin treatment reduced autoantibody production, inhibited T lymphocyte and subsequent B cell acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jilu, Wang, Xun, Wang, Renxi, Chen, Guojiang, Wang, Jing, Feng, Jiannan, Li, Yan, Yu, Zuyin, Xiao, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045991/ https://www.ncbi.nlm.nih.gov/pubmed/36979928 http://dx.doi.org/10.3390/biomedicines11030949

Ejemplares similares

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells.
por: Zhang, Jilu, et al.
Publicado: (2019)

Lupus Recipe inhibits cGVHD‐induced lupus nephritis in mice and promote renal LC3‐associated autophagy
por: Liu, Ruihua, et al.
Publicado: (2023)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
por: Zhang, Chenzhu, et al.
Publicado: (2022)

B cells regulate thymic CD8(+)T cell differentiation in lupus-prone mice
por: Xing, Chen, et al.
Publicado: (2017)

Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
por: Chen, Guojiang, et al.
Publicado: (2009)

Mesangial cell: A hub in lupus nephritis
por: Liu, Mengdi, et al.
Publicado: (2022)

Modulation of Allogeneic CD8(+) T-Cell Response by DZNep Controls GVHD While Preserving Hematopoietic Chimerism
por: Wang, Jina, et al.
Publicado: (2013)

Human Amniotic Mesenchymal Stem Cells Inhibit aGVHD by Regulating Balance of Treg and T Effector Cells
por: Gao, Ya, et al.
Publicado: (2021)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Lupus nephritis or not? A simple and clinically friendly machine learning pipeline to help diagnosis of lupus nephritis
por: Wang, Da-Cheng, et al.
Publicado: (2023)

Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
por: Strauss, Laura, et al.
Publicado: (2009)

Accelerated Glomerular Cell Senescence in Experimental Lupus Nephritis
por: Yang, Chen, et al.
Publicado: (2018)

Targeting Regulatory T Cells for Therapy of Lupus Nephritis
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

Lupus Nephritis Associated With Renal Cell Carcinoma
por: Mehta, Vivek, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Fluvastatin-Pretreated Donor Cells Attenuated Murine aGVHD by Balancing Effector T Cell Distribution and Function under the Regulation of KLF2
por: Zhao, Kai, et al.
Publicado: (2020)

Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality
por: Holtan, Shernan G., et al.
Publicado: (2023)

Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4(+)CD25(+)Foxp3(+) Treg cells in an MRL/lpr mouse model
por: Gao, Yan-fang, et al.
Publicado: (2022)

Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy
por: Yu, Yunxia, et al.
Publicado: (2021)

Immune Complexes Impaired Glomerular Endothelial Cell Functions in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2019)

High-Throughput Sequencing-Based Analysis of T Cell Repertoire in Lupus Nephritis
por: Ye, Xiaolan, et al.
Publicado: (2020)

Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis
por: Pamfil, Cristina, et al.
Publicado: (2018)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Lupus Nephritis in a Patient with Sickle Cell Disease
por: Minocha, Vinay, et al.
Publicado: (2013)

Circulating Angiogenic T Cells Are Increased in Lupus Nephritis Patients
por: Zhao, Peng, et al.
Publicado: (2018)

Single-cell RNA sequencing for the study of lupus nephritis
por: Der, Evan, et al.
Publicado: (2019)

The immune cell landscape in kidneys of patients with lupus nephritis
por: Arazi, Arnon, et al.
Publicado: (2019)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Anti-TWEAK Antibody Alleviates Renal Interstitial Fibrosis by Increasing PGC-1α Expression in Lupus Nephritis
por: Xue, Leixi, et al.
Publicado: (2021)

Transcriptomics analysis of sirolimus treatment in lupus nephritis
por: Wang, Dongdong, et al.
Publicado: (2019)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lrfggo5vr3ag80btjjrspp4c7b